Diagnosis and management of early non-immune hydrops fetalis
- 4 December 1997
- journal article
- review article
- Published by Wiley in Prenatal Diagnosis
- Vol. 17 (13) , 1261-1268
- https://doi.org/10.1002/(sici)1097-0223(199712)17:13<1261::aid-pd292>3.0.co;2-c
Abstract
Fetal hydrops is a common symptom of fetal disease at any stage of gestation. The aetiological mechanisms leading to non‐immune fetal hydrops are complex and their impact variable at different stages of gestation. In early pregnancy, primary or secondary intra‐uterine cardiac failures due to major cardiovascular defects are more often linked to a chromosomal abnormality than during the second half of gestation. In these cases, an increase of the nuchal translucency thickness is probably the first stage of fetal hydrops. Depending on the severity of the underlying defect, the next stage is generalized skin oedema with eventual placental oedema, ascites and pleural effusion. The natural history of fetal hydrops remains poorly understood and thus the prognostic factors determining fetal outcome are still unknown. Examination of the fetal nuchal anatomy between 10 and 15 weeks of gestation and the follow‐up of these pregnancies offer an opportunity for an early screening in most aneuploidies and cardiovascular defects, and a better understanding of the aetiopathology of fetal hydrops. © 1997 by John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetusesPublished by Wolters Kluwer Health ,1999
- Outcome of Nonimmune Hydrops Fetalis Diagnosed During the First Half of PregnancyPublished by Wolters Kluwer Health ,1998
- Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetusesAmerican Journal of Medical Genetics, 1997
- PATHOLOGICAL SIGNIFICANCE OF FIRST-TRIMESTER FETAL NUCHAL OEDEMAPrenatal Diagnosis, 1996
- Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 1l–13 weeks of gestationUltrasound in Obstetrics & Gynecology, 1996
- First-trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21American Journal of Obstetrics and Gynecology, 1995
- Ultrasound measurement of placental thickness to detect pregnancies affected by homozygous α-thalassaemia-1The Lancet, 1994
- Congenital anaemia after transplacental B19 parvovirus infectionThe Lancet, 1994
- Bilateral pleural effusion at 8.5 weeks' gestation with Down syndrome and Turner syndromePrenatal Diagnosis, 1993
- Chromosomal anomalies in fetal congenital heart diseaseUltrasound in Obstetrics & Gynecology, 1991